Shire Plc Ads (NQ: SHPG )

N/A USD UNCHANGED

Last Price Updated: 9:13 AM EST, Jan 7, 2019 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	164.20 (5)
Ask (Size)	179.55 (5)
Prev. Close	-
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

FDA approves Shire’s Motegrity™ (prucalopride), the only serotonin-4 receptor agonist for adults with Chronic Idiopathic Constipation (CIC)

December 16, 2018

Annual Changes to the NASDAQ-100 Index

December 14, 2018

Nasdaq (Nasdaq: NDAQ) today announced the results of the annual re-ranking of the NASDAQ-100 Index® (Nasdaq: NDX), which will become effective prior to market open on Monday, December 24, 2018.

Performance

More News

Initial Data from Shire Collaboration Identifies Key Biomarkers That Affect Bleeding Patterns, Response to Treatment for Hemophilia A

December 01, 2018

Shire Receives European Approval for TAKHZYRO™ (lanadelumab) subcutaneous injection, for the Preventive Treatment of Hereditary Angioedema

November 29, 2018

Report: Developing Opportunities within Liberty TripAdvisor, Chanticleer, Retrophin, Menlo Therapeutics, Shire plc, and Matthews International — Future Expectations, Projections Moving into 2018

November 28, 2018

Interesting SHPG Put And Call Options For February 15th

January 03, 2019

Why Mirum Pharmaceuticals Stock Skyrocketed 44% Today

December 18, 2019

Biotechs Were Innovators In 2018: Here Are The Top New Molecules That Were Approved

December 18, 2018

3 Stocks to Hold for the Next 20 Years

July 11, 2019

Here's Why BioCryst Pharmaceuticals Collapsed Today

May 21, 2019

Nasdaq 100 Movers: CTRP, SHPG

December 06, 2018

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.